REQUEST A DEMO
Total
USD $0.00
Search more companies

Unidad Clinica del Sistema Nervioso Limitada (Colombia)

Main Activities: Hospitals
Full name: Unidad Clinica del Sistema Nervioso Limitada Profile Updated: November 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Unidad Clinica del Sistema Nervioso Limitada is a company based in Colombia, with its head office in Villavicencio. The enterprise operates in the Hospitals industry. It was incorporated on April 12, 1997. It currently has a total number of 35 (2012) employees. In 2023, the company reported a net sales revenue increase of 2.01%. A growth of 8.34% was recorded in its total assets. In, 2023, the company’s net profit margin decreased by 0.01%.

Headquarters
Calle 33 N 42 30
Villavicencio; Meta;

Contact Details: Purchase the Unidad Clinica del Sistema Nervioso Limitada report to view the information.

Basic Information
Total Employees:
Purchase the Unidad Clinica del Sistema Nervioso Limitada report to view the information.
Outstanding Shares:
Purchase the Unidad Clinica del Sistema Nervioso Limitada report to view the information.
Incorporation Date:
April 12, 1997
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Unidad Clinica del Sistema Nervioso Limitada report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
2.01%
Total operating revenue
2.01%
Operating profit (EBIT)
9.68%
EBITDA
22.73%
Net Profit (Loss) for the Period
1.9%
Total assets
8.34%
Total equity
17.93%
Operating Profit Margin (ROS)
1.88%
Net Profit Margin
-0.01%
Return on Equity (ROE)
-2.42%
Debt to Equity Ratio
-10.78%
Quick Ratio
0.11%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?